Work

Novel CD2-Targeting Trispecific Immune Effector Cell Engager (TRIEC) Coupled with CD19 CAR-T Overcomes Resistant B-Cell Lymphoma

Year: 2024

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2024-194688

Authors: Elijah P Darnell, Hana N Takei, Mark B Leick, Filippo Birocchi, Amanda A Bouffard, Trisha R Berger, Marcela V Maus

Institutions: Harvard University, Massachusetts General Hospital, Dana-Farber Cancer Institute

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4405041471

Cites:

Cited by:

Related to: 10